ARCHIVES

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

This article is from The Cancer Letter archive.

Vol. 38 No. 07 | February 17, 2012

Download PDF Visit The Full Archive

Related Articles

RFA Announcement On Carcinogenesis Extrapolation

August 1, 1980

Investigators Present Latest Data On Immunologic Control of Tumors

June 1, 1975

In Brief: Phil Web, Former NCI Contracts Official, Dies; Minimal Breast Cancer Workshop Set

February 15, 1980

NIH Carcinogen Guidelines Offered

April 24, 1981

Saffiotti Couldn’t Cope With Demands Of National Program, Rauscher Says In Letter To Kennedy

June 11, 1976

In Brief: Fischinger Hints of “New Player” At FCRF; Gigliotti Named Cancer Control Science Director

December 12, 1986